Toru Maruyama

Title: Toru Maruyama: Innovator in Bilirubin Excretion Enhancement

Introduction

Toru Maruyama is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of medical therapies, particularly in addressing hyperbilirubinemia. His innovative approach has led to the development of a unique bilirubin excretion enhancer.

Latest Patents

Maruyama holds a patent for a bilirubin excretion enhancer, which aims to establish a novel therapy method for hyperbilirubinemia. The invention provides a bilirubin excretion enhancer that comprises, as an active ingredient, a serum albumin domain II-like protein. This protein includes a serum albumin subdomain IIA, which has an amino acid sequence of SEQ ID NO: 1. In one embodiment, the serum albumin domain II-like protein is a serum albumin domain II, which comprises the amino acid sequence of SEQ ID NO: 4. He has 1 patent to his name.

Career Highlights

Toru Maruyama is associated with Nipro Corporation, where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in his area of expertise.

Collaborations

Maruyama has collaborated with notable colleagues, including Yu Ishima and Masaki Otagiri. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Toru Maruyama's work in developing a bilirubin excretion enhancer showcases his commitment to improving medical therapies for hyperbilirubinemia. His innovative contributions and collaborations highlight the importance of research in advancing healthcare solutions.